Literature DB >> 10672306

Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading.

R Wagener1, G Röhn, G Schillinger, R Schröder, B Kobbe, R I Ernestus.   

Abstract

The composition and the content of gangliosides changes during physiological growth and differentiation as well as in neoplastic cell transformation. In order to determine if ganglioside profiles correlate with brain tumour malignancy, the ganglioside distribution was determined in 31 gliomas of astrocytic origin and in non-tumour tissue by a recently developed microbore high performance liquid chromatography (HPLC) method. Glioma malignancy was graded according to the grading system proposed by the World Health Organization (WHO) in 1993. In general, an increase of GD3 and a decrease of normal brain gangliosides correlated with a higher grade of malignancy. Pilocytic astrocytomas Grade I had a distinctive ganglioside profile, histologically as well as biochemically. Although they are low-grade gliomas, the pilocytic astrocytomas exhibited a GD3 content comparable to anaplastic gliomas and could only be biochemically distinguished from other tumour grades by relatively high type "b" ganglioside levels. Thus, ganglioside composition not only reflects anaplasia but can also be used to indicate biological characteristics of tumours of different histogenetic origin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672306     DOI: 10.1007/s007010050439

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.

Authors:  Yuki Ohkawa; Hiroyuki Momota; Akira Kato; Noboru Hashimoto; Yusuke Tsuda; Norihiro Kotani; Koichi Honke; Akio Suzumura; Keiko Furukawa; Yuhsuke Ohmi; Atsushi Natsume; Toshihiko Wakabayashi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

2.  Glioma growth inhibition by neurostatin and O-But GD1b.

Authors:  Beatriz Valle-Argos; Diego Gómez-Nicola; Manuel Nieto-Sampedro
Journal:  Neuro Oncol       Date:  2010-07-08       Impact factor: 12.300

3.  Activity of lysosomal exoglycosidases in human gliomas.

Authors:  P Wielgat; U Walczuk; S Szajda; M Bień; L Zimnoch; Z Mariak; K Zwierz
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

4.  Discrimination of human astrocytoma subtypes by lipid analysis using desorption electrospray ionization imaging mass spectrometry.

Authors:  Livia S Eberlin; Allison L Dill; Alexandra J Golby; Keith L Ligon; Justin M Wiseman; R Graham Cooks; Nathalie Y R Agar
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

5.  Scientific literature addressing detection of monosialoganglioside: A 10-year bibliometric analysis.

Authors:  Yanli Xu; Miaojing Li; Zhijun Liu; Aiping Xi; Chaoxian Zhao; Jianzhong Zhang
Journal:  Neural Regen Res       Date:  2012-04-05       Impact factor: 5.135

Review 6.  Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Authors:  Andrea Gras Navarro; Andreas T Björklund; Martha Chekenya
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

7.  Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells.

Authors:  Nathalie Baeza-Kallee; Raphaël Bergès; Aurélie Soubéran; Carole Colin; Emilie Denicolaï; Romain Appay; Aurélie Tchoghandjian; Dominique Figarella-Branger
Journal:  Cancers (Basel)       Date:  2019-08-28       Impact factor: 6.639

8.  GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.

Authors:  Barun Mahata; Soumika Biswas; Patricia Rayman; Ali Chahlavi; Jennifer Ko; Ashish Bhattacharjee; Yu-Teh Li; Yuntao Li; Tanya Das; Gaurisankar Sa; Baisakhi Raychaudhuri; Michael A Vogelbaum; Charles Tannenbaum; James H Finke; Kaushik Biswas
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.